*	OR T1 T2
*	OR T6 T5
R1	Has_negation Arg1:T9 Arg2:T8	
R2	AND Arg1:T7 Arg2:T9	
R3	AND Arg1:T11 Arg2:T10	
R4	Subsumes Arg1:T13 Arg2:T14	
R5	Subsumes Arg1:T15 Arg2:T16	
*	OR T13 T15
R6	Has_value Arg1:T13 Arg2:T17	
R7	Subsumes Arg1:T12 Arg2:T13	
*	OR T12 T19 T20
R8	Has_negation Arg1:T23 Arg2:T22	
R9	Has_index Arg1:T25 Arg2:T26	
R10	Has_temporal Arg1:T24 Arg2:T25	
*	OR T21 T24 T27
*	OR T31 T32
R11	Has_negation Arg1:T31 Arg2:T30	
R12	Has_qualifier Arg1:T27 Arg2:T29	
R13	Has_temporal Arg1:T27 Arg2:T28	
R14	AND Arg1:T27 Arg2:T31	
R15	Has_qualifier Arg1:T34 Arg2:T35	
R16	Has_value Arg1:T37 Arg2:T38	
*	OR T34 T36
R17	Has_context Arg1:T34 Arg2:T37	
T1	Observation 26 39	suicidal risk
T2	Observation 47 55	violence
T3	Condition 88 96	Delirium
T4	Condition 98 106	Dementia
T5	Condition 127 145	cognitive disorder
T6	Condition 108 116;137 145	Amnestic disorder
T7	Condition 175 189	hypothyroidism
T8	Negation 190 196	unless
T9	Drug 221 239	thyroid medication
T10	Condition 350 365	substance abuse
T11	Measurement 303 312	DSM-IV-TR
T12	Condition 368 389	hepatic insufficiency
T13	Measurement 439 465	aspartate aminotransferase
T14	Measurement 467 470	AST
T15	Measurement 479 503	alanine aminotransferase
T16	Measurement 505 508	ALT
T17	Value 391 428	three times the upper limit of normal
T19	Procedure 512 528	liver transplant
T20	Condition 540 562	cirrhosis of the liver
T21	Condition 565 575	malignancy
T22	Negation 577 583	except
T23	Condition 584 604	basal cell carcinoma
T24	Procedure 613 625	chemotherapy
T25	Temporal 626 658	within 1 year prior to screening
T26	Reference_point 649 658	screening
T27	Condition 660 670	malignancy
T28	Temporal 671 687	more than 1 year
T29	Qualifier 722 727	local
T30	Negation 732 739	without
T31	Condition 740 750	metastasis
T32	Condition 758 768	recurrence
T34	Condition 864 881	medical condition
T35	Qualifier 855 863	unstable
T36	Condition 885 909	life threatening disease
T37	Observation 915 935	anticipated survival
T38	Value 939 957	less than 6 months
T40	Non-query-able 960 1040	need for therapies that may obscure the results of treatment and/or of the study
T41	Competing_trial 1042 1119	Participation in another clinical trial within 30 days of the screening visit
T42	Post-eligibility 1122 1176	Anticipated inability to attend scheduled study visits
T43	Non-query-able 1179 1318	Patients who in the judgment of the Investigator may be unreliable or uncooperative with the evaluation procedure outlined in this protocol
T44	Competing_trial 1321 1377	Patients with a history of prior pharmacogenomic testing
T45	Procedure 1394 1417	psychotropic medication
T46	Pregnancy_considerations 1480 1530	Patients who are known to be pregnant or lactating
T47	Procedure 1560 1582	gastric bypass surgery
